SAMYANG BIOPHARMACEUTICALS CORPORATION;TRANSDERM INC.
发明人:
HEE-SOOK KIM,HYUN-SUK YU,HYUN-WOO KIM,YOUNG-MOO LEE
申请号：
BR112013016266
公开号：
BR112013016266A2
申请日:
2011.12.22
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
Disclosed is a percutaneous absorption preparation for treatment of dementia that comprises rivastigmine or its pharmaceutically acceptable salt as an active ingredient, a styrene-isoprene-styrene block copolymer, a tackifier resin, and a plasticizer, which preparation contains a small amount of rivastigmine but allows a sufficient amount of the active ingredient penetrated into the skin to achieve an effective treatment of dementia.
